Allscripts Healthcare Solutions (Nasdaq: MDRX) reported earnings on May 9. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended March 31 (Q1), Allscripts Healthcare Solutions missed estimates on revenues and missed estimates on earnings per share.

Compared to the prior-year quarter, revenue dropped. Non-GAAP earnings per share shrank significantly. GAAP earnings per share shrank to a loss.

Gross margins expanded, operating margins shrank, net margins shrank.

Revenue details
Allscripts Healthcare Solutions reported revenue of $347.1 million. The 18 analysts polled by S&P Capital IQ hoped for net sales of $367.5 million on the same basis. GAAP reported sales were the same as the prior-year quarter's.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
EPS came in at $0.09. The 20 earnings estimates compiled by S&P Capital IQ predicted $0.14 per share. Non-GAAP EPS of $0.09 for Q1 were 25% lower than the prior-year quarter's $0.12 per share. GAAP EPS were -$0.07 for Q1 compared to $0.03 per share for the prior-year quarter.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 44.4%, 170 basis points better than the prior-year quarter. Operating margin was -8.2%, much worse than the prior-year quarter. Net margin was -3.3%, 490 basis points worse than the prior-year quarter. (Margins calculated in GAAP terms.)

Looking ahead
Next quarter's average estimate for revenue is $371.2 million. On the bottom line, the average EPS estimate is $0.15.

Next year's average estimate for revenue is $1.49 billion. The average EPS estimate is $0.65.

Investor sentiment
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 432 members out of 461 rating the stock outperform, and 29 members rating it underperform. Among 117 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 110 give Allscripts Healthcare Solutions a green thumbs-up, and seven give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Allscripts Healthcare Solutions is hold, with an average price target of $13.08.

Is Allscripts Healthcare Solutions the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis -- even one of our own -- helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.